Heliad Equity Partners GmbH & Co. KGaA: Portfolio Investment Vanguard concludes major deal in the UK

Heliad Equity Partners GmbH & Co. KGaA / Miscellaneous

Corporate news transmitted by DGAP - a company of EquityStory AG. The issuer is solely responsible for the content of this announcement.

++ Heliad portfolio investment Vanguard concludes major deal worth EUR 180    million in the UK

++ Takeover of sterile supply services and instrument management at BMI Healthcare, the largest private hospital chain in Great Britain
The Berlin-based high-tech medical services provider Vanguard, a portfolio investment of Heliad Equity Partners, has recently announced it will takeover the provision of sterile supply services and instrument management for the UK hospital chain BMI Healthcare. The BMI Healthcare Group comprises 49 private maximum care hospitals in the United Kingdom with a total of more than 2,400 beds. Around 250,000 in-patients and 750,000 out-patients are cared for each year. As a subsidiary of the General Health Care Group (GHG), BMI is part of one of the leading private hospital chains in Great Britain.

According to information provided by Vanguard, the total order volume amounts to around EUR 180 million, spread over an initial term of 12 years. Vanguard will install several new systems for GHG, which will be used to guarantee the provision of healthcare services to the total of 117 operation theatres via an advanced logistics system, which is also yet to be installed. Two existing systems in Glasgow and Manchester will also be supported from February 2007. This will be followed immediately afterwards by the construction of four further high-tech care centres with scalable care capacities in North Kent, North West London, South West London and Birmingham. In future these centres could also provide care for further clinics in the area.

For Heliad Managing Director Andreas Lange, the deal with BMI/GHG represents a significant milestone in Vanguard’s development: 'Having already made an extremely successful market entry in a number of European countries, in securing this major deal, the German market leader Vanguard has provided further evidence that its expansion abroad is on an extremely solid footing. At the same time, the long-running contracts with the clinics are generating high income stability and predictability, making it possible to plan Vanguard’s future success with a high degree of certainty.'

Heliad Equity Partners GmbH & Co. KGaA 
Christiane Kriesche
Leiterin Marketing & Kommunikation
Grüneburgweg 18
60322 Frankfurt

Tel.: +49(0)69 719 15 965 17
Fax: +49(0)69 719 15 965 17
E-Mail: christiane.kriesche@sigma-capital.de

DGAP 17.01.2007 

Language:     English
Issuer: Heliad Equity Partners GmbH & Co. KGaA               Grüneburgweg 18
              60322 Frankfurt am Main Deutschland
Phone:        +49 (0)69 719 15 965 0
Fax:          +49(0)69 719 15 965 11
E-mail: christiane.kriesche@sigma-capital.de WWW:          www.heliad.de
ISIN:         DE0006047293
WKN:          604729
Listed: Geregelter Markt in Frankfurt (Prime Standard); Freiverkehr in Berlin-Bremen, München, Stuttgart  
End of News DGAP News-Service